Page 1 - CIMA SCS Workbook November 2018 - Day 1 Suggested Solutions

Day 1 Suggested Solutions

Chapter 11

SUGGESTED SOLUTIONS

CHAPTER TWO - QUIZ

Question Your response

1. How many factories does Novak 12 factories in 10 countries – p.17
operate, and in how many
countries?

2. Which is the biggest global Horter – p.3
pharmaceutical company by
revenue?

3. In what year did Novak become a 1960 – p.9
quoted company?

4. Who is the Director of Finance at Randal Edwards – p.14
Novak?

5. How has Novak’s share price It has fallen by roughly 1/3, from around
performed over the last 5 years? $450/share to just below $300 – p.24

6. Who does Novak sell pharmaceutical Larger pharmacies, such as those in larger
products to? hospitals and major chains of retail pharmacists;
and also to specialist wholesalers who then supply
smaller pharmacies – p.11

7. How many acquisitions did Novak 3 – p.12
make last year?
8. Which pharmaceutical company has Werstra – p.25
developed Denovax?

9. What percentage of its earnings did 89% (9,000/10,117) – p.19
Novak pay out as a dividend for the
year to 31.12.2017?

10. What is the value of the global sales More than US$1,100 billion – p.3
of pharmaceutical products?
11. What is the main focus of the PRA? The budgetary implications of approving a new
drug – p.8

KAPLAN PUBLISHING 41